Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children

Asthmatic symptoms and the frequency of admissions to hospital because of acute asthma tend to increase in the early morning hours, and it is therefore possible that airway inflammation increases during the night. To elucidate the hypothetical circadian variation of airway inflammation, we measured...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric research 2002-02, Vol.51 (2), p.190-194
Hauptverfasser: MATTES, Joerg, VAN'S GRAVESANDE, Karin Storm, MOELLER, Caroline, MOSELER, Michael, BRANDIS, Matthias, KUEHR, Joachim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue 2
container_start_page 190
container_title Pediatric research
container_volume 51
creator MATTES, Joerg
VAN'S GRAVESANDE, Karin Storm
MOELLER, Caroline
MOSELER, Michael
BRANDIS, Matthias
KUEHR, Joachim
description Asthmatic symptoms and the frequency of admissions to hospital because of acute asthma tend to increase in the early morning hours, and it is therefore possible that airway inflammation increases during the night. To elucidate the hypothetical circadian variation of airway inflammation, we measured concentrations of exhaled nitric oxide (FeNo), urinary eosinophil protein X excretion (EPX), and forced expiratory volume in the first second (FEV1) in 20 asthmatic and 6 nonatopic nonasthmatic children every 3 h during a 21-h period. Compared with control subjects, asthmatic subjects had higher FeNo (median, 22.7 versus 10.3 ppb, p = 0.016) and lower FEV1 % predicted (median, 91.0 versus 101.9%, p = 0.045), but did not differ significantly in EPX (median, 153.8 versus 148.7 microg/mmol creatinine, p = 0.83) at 7 AM. However, differences in gender and age do not allow direct comparisons between asthmatic and control children. FeNo and EPX demonstrated a cosinelike circadian rhythm (log FeNo, p = 0.0001; log EPX, p = 0.0001) with lowest levels at 7 PM and highest at 7 AM. This was also the case for FEV1 % (p = 0.01). No difference in the amplitude of circadian rhythm was observed between asthmatic and healthy control children for log FeNo (p = 0.35), log EPX (p = 0.57), and FEV1 % (p = 0.17). A stratified analysis showed a significant circadian rhythm in the control group for log FeNo (p = 0.014) and log EPX (p = 0.0001). Our results therefore suggest a circadian rhythm of inflammatory markers, which peaks in the early morning. Rhythmicity of EPX excretion and FeNo in healthy children suggests a physiologic mechanism; however, pathologic effects during the night might occur under conditions of asthma-specific inflammation.
doi_str_mv 10.1203/00006450-200202000-00011
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1203_00006450_200202000_00011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11809913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-fc09fa19419b8129655e5dccdbbd822a21bb6e981779583358ce7e6eaa4bb53a3</originalsourceid><addsrcrecordid>eNpFkF1LwzAUhoMobk7_guTGy2o-2-RShl8w8EbBu3KapDTSpSXpZPv3xm1qDjmHwPMewoMQpuSWMsLvSD6lkKRghLBchBT5UnqC5lTy_BCiOkVzQjgtuNZqhi5S-syEkEqcoxmlimhN-RyFpY8GrIeAvyB6mPwQ8NBit-2gdxYHP0Vv8LD11mEIFm-iDxB32A3Jh2HsfI_HOEzOB_yBc4M0deu8xuzpzkE_dTtsMmejC5forIU-uavjXKD3x4e35XOxen16Wd6vCiNkNRWtIboFqgXVjaJMl1I6aY2xTWMVY8Bo05ROK1pVWirOpTKucqUDEE0jOfAFUoe9Jg4pRdfWY_Tr_O-akvpHYf2rsP5TWO8V5uj1ITpumrWz_8GjswzcHAFIBvo2QjA-_XNcSKEU499yz3rX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Journals@Ovid Complete</source><creator>MATTES, Joerg ; VAN'S GRAVESANDE, Karin Storm ; MOELLER, Caroline ; MOSELER, Michael ; BRANDIS, Matthias ; KUEHR, Joachim</creator><creatorcontrib>MATTES, Joerg ; VAN'S GRAVESANDE, Karin Storm ; MOELLER, Caroline ; MOSELER, Michael ; BRANDIS, Matthias ; KUEHR, Joachim</creatorcontrib><description>Asthmatic symptoms and the frequency of admissions to hospital because of acute asthma tend to increase in the early morning hours, and it is therefore possible that airway inflammation increases during the night. To elucidate the hypothetical circadian variation of airway inflammation, we measured concentrations of exhaled nitric oxide (FeNo), urinary eosinophil protein X excretion (EPX), and forced expiratory volume in the first second (FEV1) in 20 asthmatic and 6 nonatopic nonasthmatic children every 3 h during a 21-h period. Compared with control subjects, asthmatic subjects had higher FeNo (median, 22.7 versus 10.3 ppb, p = 0.016) and lower FEV1 % predicted (median, 91.0 versus 101.9%, p = 0.045), but did not differ significantly in EPX (median, 153.8 versus 148.7 microg/mmol creatinine, p = 0.83) at 7 AM. However, differences in gender and age do not allow direct comparisons between asthmatic and control children. FeNo and EPX demonstrated a cosinelike circadian rhythm (log FeNo, p = 0.0001; log EPX, p = 0.0001) with lowest levels at 7 PM and highest at 7 AM. This was also the case for FEV1 % (p = 0.01). No difference in the amplitude of circadian rhythm was observed between asthmatic and healthy control children for log FeNo (p = 0.35), log EPX (p = 0.57), and FEV1 % (p = 0.17). A stratified analysis showed a significant circadian rhythm in the control group for log FeNo (p = 0.014) and log EPX (p = 0.0001). Our results therefore suggest a circadian rhythm of inflammatory markers, which peaks in the early morning. Rhythmicity of EPX excretion and FeNo in healthy children suggests a physiologic mechanism; however, pathologic effects during the night might occur under conditions of asthma-specific inflammation.</description><identifier>ISSN: 0031-3998</identifier><identifier>EISSN: 1530-0447</identifier><identifier>DOI: 10.1203/00006450-200202000-00011</identifier><identifier>PMID: 11809913</identifier><identifier>CODEN: PEREBL</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adolescent ; Allergic diseases ; Anti-Inflammatory Agents - metabolism ; Asthma - immunology ; Asthma - physiopathology ; Asthma - urine ; Biological and medical sciences ; Child ; Circadian Rhythm ; Eosinophil-Derived Neurotoxin ; Female ; Forced Expiratory Volume ; Humans ; Hydrocortisone - metabolism ; Immunopathology ; Male ; Medical Records ; Medical sciences ; Nitric Oxide - metabolism ; Respiratory and ent allergic diseases ; Ribonucleases - urine ; Saliva - chemistry</subject><ispartof>Pediatric research, 2002-02, Vol.51 (2), p.190-194</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-fc09fa19419b8129655e5dccdbbd822a21bb6e981779583358ce7e6eaa4bb53a3</citedby><cites>FETCH-LOGICAL-c457t-fc09fa19419b8129655e5dccdbbd822a21bb6e981779583358ce7e6eaa4bb53a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13454882$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11809913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MATTES, Joerg</creatorcontrib><creatorcontrib>VAN'S GRAVESANDE, Karin Storm</creatorcontrib><creatorcontrib>MOELLER, Caroline</creatorcontrib><creatorcontrib>MOSELER, Michael</creatorcontrib><creatorcontrib>BRANDIS, Matthias</creatorcontrib><creatorcontrib>KUEHR, Joachim</creatorcontrib><title>Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children</title><title>Pediatric research</title><addtitle>Pediatr Res</addtitle><description>Asthmatic symptoms and the frequency of admissions to hospital because of acute asthma tend to increase in the early morning hours, and it is therefore possible that airway inflammation increases during the night. To elucidate the hypothetical circadian variation of airway inflammation, we measured concentrations of exhaled nitric oxide (FeNo), urinary eosinophil protein X excretion (EPX), and forced expiratory volume in the first second (FEV1) in 20 asthmatic and 6 nonatopic nonasthmatic children every 3 h during a 21-h period. Compared with control subjects, asthmatic subjects had higher FeNo (median, 22.7 versus 10.3 ppb, p = 0.016) and lower FEV1 % predicted (median, 91.0 versus 101.9%, p = 0.045), but did not differ significantly in EPX (median, 153.8 versus 148.7 microg/mmol creatinine, p = 0.83) at 7 AM. However, differences in gender and age do not allow direct comparisons between asthmatic and control children. FeNo and EPX demonstrated a cosinelike circadian rhythm (log FeNo, p = 0.0001; log EPX, p = 0.0001) with lowest levels at 7 PM and highest at 7 AM. This was also the case for FEV1 % (p = 0.01). No difference in the amplitude of circadian rhythm was observed between asthmatic and healthy control children for log FeNo (p = 0.35), log EPX (p = 0.57), and FEV1 % (p = 0.17). A stratified analysis showed a significant circadian rhythm in the control group for log FeNo (p = 0.014) and log EPX (p = 0.0001). Our results therefore suggest a circadian rhythm of inflammatory markers, which peaks in the early morning. Rhythmicity of EPX excretion and FeNo in healthy children suggests a physiologic mechanism; however, pathologic effects during the night might occur under conditions of asthma-specific inflammation.</description><subject>Adolescent</subject><subject>Allergic diseases</subject><subject>Anti-Inflammatory Agents - metabolism</subject><subject>Asthma - immunology</subject><subject>Asthma - physiopathology</subject><subject>Asthma - urine</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Circadian Rhythm</subject><subject>Eosinophil-Derived Neurotoxin</subject><subject>Female</subject><subject>Forced Expiratory Volume</subject><subject>Humans</subject><subject>Hydrocortisone - metabolism</subject><subject>Immunopathology</subject><subject>Male</subject><subject>Medical Records</subject><subject>Medical sciences</subject><subject>Nitric Oxide - metabolism</subject><subject>Respiratory and ent allergic diseases</subject><subject>Ribonucleases - urine</subject><subject>Saliva - chemistry</subject><issn>0031-3998</issn><issn>1530-0447</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkF1LwzAUhoMobk7_guTGy2o-2-RShl8w8EbBu3KapDTSpSXpZPv3xm1qDjmHwPMewoMQpuSWMsLvSD6lkKRghLBchBT5UnqC5lTy_BCiOkVzQjgtuNZqhi5S-syEkEqcoxmlimhN-RyFpY8GrIeAvyB6mPwQ8NBit-2gdxYHP0Vv8LD11mEIFm-iDxB32A3Jh2HsfI_HOEzOB_yBc4M0deu8xuzpzkE_dTtsMmejC5forIU-uavjXKD3x4e35XOxen16Wd6vCiNkNRWtIboFqgXVjaJMl1I6aY2xTWMVY8Bo05ROK1pVWirOpTKucqUDEE0jOfAFUoe9Jg4pRdfWY_Tr_O-akvpHYf2rsP5TWO8V5uj1ITpumrWz_8GjswzcHAFIBvo2QjA-_XNcSKEU499yz3rX</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>MATTES, Joerg</creator><creator>VAN'S GRAVESANDE, Karin Storm</creator><creator>MOELLER, Caroline</creator><creator>MOSELER, Michael</creator><creator>BRANDIS, Matthias</creator><creator>KUEHR, Joachim</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20020201</creationdate><title>Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children</title><author>MATTES, Joerg ; VAN'S GRAVESANDE, Karin Storm ; MOELLER, Caroline ; MOSELER, Michael ; BRANDIS, Matthias ; KUEHR, Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-fc09fa19419b8129655e5dccdbbd822a21bb6e981779583358ce7e6eaa4bb53a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Allergic diseases</topic><topic>Anti-Inflammatory Agents - metabolism</topic><topic>Asthma - immunology</topic><topic>Asthma - physiopathology</topic><topic>Asthma - urine</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Circadian Rhythm</topic><topic>Eosinophil-Derived Neurotoxin</topic><topic>Female</topic><topic>Forced Expiratory Volume</topic><topic>Humans</topic><topic>Hydrocortisone - metabolism</topic><topic>Immunopathology</topic><topic>Male</topic><topic>Medical Records</topic><topic>Medical sciences</topic><topic>Nitric Oxide - metabolism</topic><topic>Respiratory and ent allergic diseases</topic><topic>Ribonucleases - urine</topic><topic>Saliva - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MATTES, Joerg</creatorcontrib><creatorcontrib>VAN'S GRAVESANDE, Karin Storm</creatorcontrib><creatorcontrib>MOELLER, Caroline</creatorcontrib><creatorcontrib>MOSELER, Michael</creatorcontrib><creatorcontrib>BRANDIS, Matthias</creatorcontrib><creatorcontrib>KUEHR, Joachim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Pediatric research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MATTES, Joerg</au><au>VAN'S GRAVESANDE, Karin Storm</au><au>MOELLER, Caroline</au><au>MOSELER, Michael</au><au>BRANDIS, Matthias</au><au>KUEHR, Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children</atitle><jtitle>Pediatric research</jtitle><addtitle>Pediatr Res</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>51</volume><issue>2</issue><spage>190</spage><epage>194</epage><pages>190-194</pages><issn>0031-3998</issn><eissn>1530-0447</eissn><coden>PEREBL</coden><abstract>Asthmatic symptoms and the frequency of admissions to hospital because of acute asthma tend to increase in the early morning hours, and it is therefore possible that airway inflammation increases during the night. To elucidate the hypothetical circadian variation of airway inflammation, we measured concentrations of exhaled nitric oxide (FeNo), urinary eosinophil protein X excretion (EPX), and forced expiratory volume in the first second (FEV1) in 20 asthmatic and 6 nonatopic nonasthmatic children every 3 h during a 21-h period. Compared with control subjects, asthmatic subjects had higher FeNo (median, 22.7 versus 10.3 ppb, p = 0.016) and lower FEV1 % predicted (median, 91.0 versus 101.9%, p = 0.045), but did not differ significantly in EPX (median, 153.8 versus 148.7 microg/mmol creatinine, p = 0.83) at 7 AM. However, differences in gender and age do not allow direct comparisons between asthmatic and control children. FeNo and EPX demonstrated a cosinelike circadian rhythm (log FeNo, p = 0.0001; log EPX, p = 0.0001) with lowest levels at 7 PM and highest at 7 AM. This was also the case for FEV1 % (p = 0.01). No difference in the amplitude of circadian rhythm was observed between asthmatic and healthy control children for log FeNo (p = 0.35), log EPX (p = 0.57), and FEV1 % (p = 0.17). A stratified analysis showed a significant circadian rhythm in the control group for log FeNo (p = 0.014) and log EPX (p = 0.0001). Our results therefore suggest a circadian rhythm of inflammatory markers, which peaks in the early morning. Rhythmicity of EPX excretion and FeNo in healthy children suggests a physiologic mechanism; however, pathologic effects during the night might occur under conditions of asthma-specific inflammation.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>11809913</pmid><doi>10.1203/00006450-200202000-00011</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0031-3998
ispartof Pediatric research, 2002-02, Vol.51 (2), p.190-194
issn 0031-3998
1530-0447
language eng
recordid cdi_crossref_primary_10_1203_00006450_200202000_00011
source MEDLINE; SpringerLink (Online service); Alma/SFX Local Collection; EZB Electronic Journals Library; Journals@Ovid Complete
subjects Adolescent
Allergic diseases
Anti-Inflammatory Agents - metabolism
Asthma - immunology
Asthma - physiopathology
Asthma - urine
Biological and medical sciences
Child
Circadian Rhythm
Eosinophil-Derived Neurotoxin
Female
Forced Expiratory Volume
Humans
Hydrocortisone - metabolism
Immunopathology
Male
Medical Records
Medical sciences
Nitric Oxide - metabolism
Respiratory and ent allergic diseases
Ribonucleases - urine
Saliva - chemistry
title Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A44%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circadian%20variation%20of%20exhaled%20nitric%20oxide%20and%20urinary%20eosinophil%20protein%20X%20in%20asthmatic%20and%20healthy%20children&rft.jtitle=Pediatric%20research&rft.au=MATTES,%20Joerg&rft.date=2002-02-01&rft.volume=51&rft.issue=2&rft.spage=190&rft.epage=194&rft.pages=190-194&rft.issn=0031-3998&rft.eissn=1530-0447&rft.coden=PEREBL&rft_id=info:doi/10.1203/00006450-200202000-00011&rft_dat=%3Cpubmed_cross%3E11809913%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11809913&rfr_iscdi=true